Review



zikv vlps  (Native Antigen Inc)


Bioz Verified Symbol Native Antigen Inc is a verified supplier
Bioz Manufacturer Symbol Native Antigen Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Native Antigen Inc zikv vlps
    Zikv Vlps, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 92/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/zikv vlps/product/Native Antigen Inc
    Average 92 stars, based on 8 article reviews
    zikv vlps - by Bioz Stars, 2026-04
    92/100 stars

    Images



    Similar Products

    92
    Native Antigen Inc zikv vlps
    Zikv Vlps, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/zikv vlps/product/Native Antigen Inc
    Average 92 stars, based on 1 article reviews
    zikv vlps - by Bioz Stars, 2026-04
    92/100 stars
      Buy from Supplier

    92
    Native Antigen Inc zika virus vlp
    Zika Virus Vlp, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/zika virus vlp/product/Native Antigen Inc
    Average 92 stars, based on 1 article reviews
    zika virus vlp - by Bioz Stars, 2026-04
    92/100 stars
      Buy from Supplier

    92
    Native Antigen Inc zikv vlp
    Reactivity of <t>anti-ZIKV</t> MAbs. (A) Reactivity of anti-ZIKV MAbs with ZIKV and DENV virus-like particles <t>(VLP)</t> using Luminex assay. ZIKV- and DENV-VLP were conjugated to MagPlex beads (Luminex) and 10,000 beads/mL of these beads mixed with 10 μg/mL to 0.0002 ng/mL anti-ZIKV MAb 102-1, 242-3, 270-12, 289-3, 306-2, 11-3, 278-11, 78-2, and 4G2 for 90 min at room temperature. (B) Western blot analysis of anti-ZIKV MAbs. ZIKV-VLP were heat denatured under nonreduced conditions at 70°C for 5 min. Samples (left, 27 ng; right, 240 ng) were electrophoresed by Wes capillary and detected by 10 μg/mL anti-ZIKV MAb clones. Left, MAb 102-1, 242-3, 270-12, 289-3, 306-2, 78-2 and 11-3. Right, 278-11. M, molecular weight marker. The estimated molecular mass of ZIKV E protein, 55 kDa; prM protein, 23 kDa.
    Zikv Vlp, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/zikv vlp/product/Native Antigen Inc
    Average 92 stars, based on 1 article reviews
    zikv vlp - by Bioz Stars, 2026-04
    92/100 stars
      Buy from Supplier

    86
    Sartorius AG zikv vlp
    Reactivity of <t>anti-ZIKV</t> MAbs. (A) Reactivity of anti-ZIKV MAbs with ZIKV and DENV virus-like <t>particles</t> <t>(VLP)</t> using Luminex assay. ZIKV- and DENV-VLP were conjugated to MagPlex beads (Luminex) and 10,000 beads/mL of these beads mixed with 10 μg/mL to 0.0002 ng/mL anti-ZIKV MAb 102-1, 242-3, 270-12, 289-3, 306-2, 11-3, 278-11, 78-2, and 4G2 for 90 min at room temperature. (B) Western blot analysis of anti-ZIKV MAbs. ZIKV-VLP were heat denatured under nonreduced conditions at 70°C for 5 min. Samples (left, 27 ng; right, 240 ng) were electrophoresed by Wes capillary and detected by 10 μg/mL anti-ZIKV MAb clones. Left, MAb 102-1, 242-3, 270-12, 289-3, 306-2, 78-2 and 11-3. Right, 278-11. M, molecular weight marker. The estimated molecular mass of ZIKV E protein, 55 kDa; prM protein, 23 kDa.
    Zikv Vlp, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/zikv vlp/product/Sartorius AG
    Average 86 stars, based on 1 article reviews
    zikv vlp - by Bioz Stars, 2026-04
    86/100 stars
      Buy from Supplier

    92
    Native Antigen Inc zikv vlp 100
    Reactivity of <t>anti-ZIKV</t> MAbs. (A) Reactivity of anti-ZIKV MAbs with ZIKV and DENV virus-like <t>particles</t> <t>(VLP)</t> using Luminex assay. ZIKV- and DENV-VLP were conjugated to MagPlex beads (Luminex) and 10,000 beads/mL of these beads mixed with 10 μg/mL to 0.0002 ng/mL anti-ZIKV MAb 102-1, 242-3, 270-12, 289-3, 306-2, 11-3, 278-11, 78-2, and 4G2 for 90 min at room temperature. (B) Western blot analysis of anti-ZIKV MAbs. ZIKV-VLP were heat denatured under nonreduced conditions at 70°C for 5 min. Samples (left, 27 ng; right, 240 ng) were electrophoresed by Wes capillary and detected by 10 μg/mL anti-ZIKV MAb clones. Left, MAb 102-1, 242-3, 270-12, 289-3, 306-2, 78-2 and 11-3. Right, 278-11. M, molecular weight marker. The estimated molecular mass of ZIKV E protein, 55 kDa; prM protein, 23 kDa.
    Zikv Vlp 100, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/zikv vlp 100/product/Native Antigen Inc
    Average 92 stars, based on 1 article reviews
    zikv vlp 100 - by Bioz Stars, 2026-04
    92/100 stars
      Buy from Supplier

    91
    Native Antigen Inc mouse anti zika virus antibody
    Reactivity of <t>anti-ZIKV</t> MAbs. (A) Reactivity of anti-ZIKV MAbs with ZIKV and DENV virus-like <t>particles</t> <t>(VLP)</t> using Luminex assay. ZIKV- and DENV-VLP were conjugated to MagPlex beads (Luminex) and 10,000 beads/mL of these beads mixed with 10 μg/mL to 0.0002 ng/mL anti-ZIKV MAb 102-1, 242-3, 270-12, 289-3, 306-2, 11-3, 278-11, 78-2, and 4G2 for 90 min at room temperature. (B) Western blot analysis of anti-ZIKV MAbs. ZIKV-VLP were heat denatured under nonreduced conditions at 70°C for 5 min. Samples (left, 27 ng; right, 240 ng) were electrophoresed by Wes capillary and detected by 10 μg/mL anti-ZIKV MAb clones. Left, MAb 102-1, 242-3, 270-12, 289-3, 306-2, 78-2 and 11-3. Right, 278-11. M, molecular weight marker. The estimated molecular mass of ZIKV E protein, 55 kDa; prM protein, 23 kDa.
    Mouse Anti Zika Virus Antibody, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti zika virus antibody/product/Native Antigen Inc
    Average 91 stars, based on 1 article reviews
    mouse anti zika virus antibody - by Bioz Stars, 2026-04
    91/100 stars
      Buy from Supplier

    90
    Native Antigen Inc zikv virus
    FIGURE 1 Isotype specificity of <t>ZIKV-immune</t> sera. ELISA plates were coated with <t>ZIKV</t> <t>NS1</t> (a, c) or ZIKV VLP (b, d), and a 1:100 dilution (n = 28) (a, b) or serial dilutions (n = 11) (c, d) of ZIKV-immune sera were added to plates. Following incubation and washes, optimized concentrations of polyclonal secondary IgG, and monoclonal Abs against the hinge or Fc portion of IgG1, IgG2, IgG3 and IgG4 Abs were added to wells (a) and (b) and IgG1 hinge Abs to (c) and (d). OD values shown at 450 nm. OD values to ZIKV VLP and ZIKV NS1 using a 1:100 dilution of ZIKV-naïve sera (n = 4), <0·2 with polyclonal secondary IgG and <0·1 with IgG1 hinge, IgG1 Fc, IgG2, IgG3 and IgG4 secondary Abs. Bars represent mean with standard error of the mean of the OD values. *P < 0·05, ***P < 0·001 and ****P < 0·0001 were obtained using the non- parametric Friedman test (three or more matched groups) with Dunn's multiple comparisons test
    Zikv Virus, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/zikv virus/product/Native Antigen Inc
    Average 90 stars, based on 1 article reviews
    zikv virus - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    91
    Native Antigen Inc zika virus zikv
    FIGURE 1 Isotype specificity of <t>ZIKV-immune</t> sera. ELISA plates were coated with <t>ZIKV</t> <t>NS1</t> (a, c) or ZIKV VLP (b, d), and a 1:100 dilution (n = 28) (a, b) or serial dilutions (n = 11) (c, d) of ZIKV-immune sera were added to plates. Following incubation and washes, optimized concentrations of polyclonal secondary IgG, and monoclonal Abs against the hinge or Fc portion of IgG1, IgG2, IgG3 and IgG4 Abs were added to wells (a) and (b) and IgG1 hinge Abs to (c) and (d). OD values shown at 450 nm. OD values to ZIKV VLP and ZIKV NS1 using a 1:100 dilution of ZIKV-naïve sera (n = 4), <0·2 with polyclonal secondary IgG and <0·1 with IgG1 hinge, IgG1 Fc, IgG2, IgG3 and IgG4 secondary Abs. Bars represent mean with standard error of the mean of the OD values. *P < 0·05, ***P < 0·001 and ****P < 0·0001 were obtained using the non- parametric Friedman test (three or more matched groups) with Dunn's multiple comparisons test
    Zika Virus Zikv, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/zika virus zikv/product/Native Antigen Inc
    Average 91 stars, based on 1 article reviews
    zika virus zikv - by Bioz Stars, 2026-04
    91/100 stars
      Buy from Supplier

    Image Search Results


    Reactivity of anti-ZIKV MAbs. (A) Reactivity of anti-ZIKV MAbs with ZIKV and DENV virus-like particles (VLP) using Luminex assay. ZIKV- and DENV-VLP were conjugated to MagPlex beads (Luminex) and 10,000 beads/mL of these beads mixed with 10 μg/mL to 0.0002 ng/mL anti-ZIKV MAb 102-1, 242-3, 270-12, 289-3, 306-2, 11-3, 278-11, 78-2, and 4G2 for 90 min at room temperature. (B) Western blot analysis of anti-ZIKV MAbs. ZIKV-VLP were heat denatured under nonreduced conditions at 70°C for 5 min. Samples (left, 27 ng; right, 240 ng) were electrophoresed by Wes capillary and detected by 10 μg/mL anti-ZIKV MAb clones. Left, MAb 102-1, 242-3, 270-12, 289-3, 306-2, 78-2 and 11-3. Right, 278-11. M, molecular weight marker. The estimated molecular mass of ZIKV E protein, 55 kDa; prM protein, 23 kDa.

    Journal: Journal of Virology

    Article Title: Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function

    doi: 10.1128/jvi.00071-22

    Figure Lengend Snippet: Reactivity of anti-ZIKV MAbs. (A) Reactivity of anti-ZIKV MAbs with ZIKV and DENV virus-like particles (VLP) using Luminex assay. ZIKV- and DENV-VLP were conjugated to MagPlex beads (Luminex) and 10,000 beads/mL of these beads mixed with 10 μg/mL to 0.0002 ng/mL anti-ZIKV MAb 102-1, 242-3, 270-12, 289-3, 306-2, 11-3, 278-11, 78-2, and 4G2 for 90 min at room temperature. (B) Western blot analysis of anti-ZIKV MAbs. ZIKV-VLP were heat denatured under nonreduced conditions at 70°C for 5 min. Samples (left, 27 ng; right, 240 ng) were electrophoresed by Wes capillary and detected by 10 μg/mL anti-ZIKV MAb clones. Left, MAb 102-1, 242-3, 270-12, 289-3, 306-2, 78-2 and 11-3. Right, 278-11. M, molecular weight marker. The estimated molecular mass of ZIKV E protein, 55 kDa; prM protein, 23 kDa.

    Article Snippet: DENV-1-VLP (Nauru/Western Pacific/1974), DENV-2-VLP (Thailand/16681/84), DENV-3-VLP (Sri Lanka D3/H/IMTSSA-SRI/2000/1266), DENV-4-VLP (Dominica/814669/1981), ZIKV-VLP (Suriname Z1106033), and ZIKV E protein (Suriname Z1106033) were purchased from The Native Antigen Company (Oxford, UK).

    Techniques: Luminex, Western Blot, Clone Assay, Molecular Weight, Marker

    Summary of characterization of  anti-ZIKV  MAbs

    Journal: Journal of Virology

    Article Title: Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function

    doi: 10.1128/jvi.00071-22

    Figure Lengend Snippet: Summary of characterization of anti-ZIKV MAbs

    Article Snippet: DENV-1-VLP (Nauru/Western Pacific/1974), DENV-2-VLP (Thailand/16681/84), DENV-3-VLP (Sri Lanka D3/H/IMTSSA-SRI/2000/1266), DENV-4-VLP (Dominica/814669/1981), ZIKV-VLP (Suriname Z1106033), and ZIKV E protein (Suriname Z1106033) were purchased from The Native Antigen Company (Oxford, UK).

    Techniques: Luminex, Western Blot

    Kinetic analysis of anti-ZIKV MAbs. Kinetic analysis was conducted by Octet HTX (Sartorius). Anti-ZIKV MAbs were conjugated to an amine-reactive 2nd generation (AR2G) biosensor at 0.1 to 0.3 μg/mL, and the association constant ( k a ) was measured over 0 to 900 s and dissociation constant ( k dis ) for 1,200 s for ZIKV-VLP or E proteins at various concentrations. (A) MAb 289-3 and 102-1 to ZIKV-VLP, 3.3 to 16.7 nM. (B) MAb 289-3 and 102-1 to ZIKV E proteins, 6.67 to 33.3 nM, red line, fitting pattern. (C) k a / k dis plot for anti-ZIKV MAbs to ZIKV-VLP and ZIKV E proteins. Blue, MAb 78-2, 289-3, 306-2 and 278-11; red, MAb 102-1, 242-3. 270-12, and 11-3. k a and k dis values were calculated by two runs, and the average values are shown. Values (nM) for equilibrium dissociation constants ( K D ) are shown for each dotted line. K D = K dis / K a .

    Journal: Journal of Virology

    Article Title: Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function

    doi: 10.1128/jvi.00071-22

    Figure Lengend Snippet: Kinetic analysis of anti-ZIKV MAbs. Kinetic analysis was conducted by Octet HTX (Sartorius). Anti-ZIKV MAbs were conjugated to an amine-reactive 2nd generation (AR2G) biosensor at 0.1 to 0.3 μg/mL, and the association constant ( k a ) was measured over 0 to 900 s and dissociation constant ( k dis ) for 1,200 s for ZIKV-VLP or E proteins at various concentrations. (A) MAb 289-3 and 102-1 to ZIKV-VLP, 3.3 to 16.7 nM. (B) MAb 289-3 and 102-1 to ZIKV E proteins, 6.67 to 33.3 nM, red line, fitting pattern. (C) k a / k dis plot for anti-ZIKV MAbs to ZIKV-VLP and ZIKV E proteins. Blue, MAb 78-2, 289-3, 306-2 and 278-11; red, MAb 102-1, 242-3. 270-12, and 11-3. k a and k dis values were calculated by two runs, and the average values are shown. Values (nM) for equilibrium dissociation constants ( K D ) are shown for each dotted line. K D = K dis / K a .

    Article Snippet: DENV-1-VLP (Nauru/Western Pacific/1974), DENV-2-VLP (Thailand/16681/84), DENV-3-VLP (Sri Lanka D3/H/IMTSSA-SRI/2000/1266), DENV-4-VLP (Dominica/814669/1981), ZIKV-VLP (Suriname Z1106033), and ZIKV E protein (Suriname Z1106033) were purchased from The Native Antigen Company (Oxford, UK).

    Techniques:

    Binding activity of framework region (FWR) amino acid reverted anti-ZIKV MAb. (A to D) Association and dissociation analysis of FWR amino acid reverted anti-ZIKV MAbs by Octet HTX (Sartorius); 2 μg/mL MAbs were captured to protein G biosensor (Sartorius), and 3 μg/mL ZIKV E protein was associated for 600 s and dissociated for 900 s. (E to H) Reactivity of anti-ZIKV MAbs of ZIKV-VLP using Luminex assay. Blue, anti-ZIKV MAbs with matured amino acid; red, anti-ZIKV MAbs with amino acid reverted to allele. (A and E) MAb 102-1. (B and F) MAb 270-12. (C and G) MAb 289-3. (D and H) MAb 306-2.

    Journal: Journal of Virology

    Article Title: Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function

    doi: 10.1128/jvi.00071-22

    Figure Lengend Snippet: Binding activity of framework region (FWR) amino acid reverted anti-ZIKV MAb. (A to D) Association and dissociation analysis of FWR amino acid reverted anti-ZIKV MAbs by Octet HTX (Sartorius); 2 μg/mL MAbs were captured to protein G biosensor (Sartorius), and 3 μg/mL ZIKV E protein was associated for 600 s and dissociated for 900 s. (E to H) Reactivity of anti-ZIKV MAbs of ZIKV-VLP using Luminex assay. Blue, anti-ZIKV MAbs with matured amino acid; red, anti-ZIKV MAbs with amino acid reverted to allele. (A and E) MAb 102-1. (B and F) MAb 270-12. (C and G) MAb 289-3. (D and H) MAb 306-2.

    Article Snippet: DENV-1-VLP (Nauru/Western Pacific/1974), DENV-2-VLP (Thailand/16681/84), DENV-3-VLP (Sri Lanka D3/H/IMTSSA-SRI/2000/1266), DENV-4-VLP (Dominica/814669/1981), ZIKV-VLP (Suriname Z1106033), and ZIKV E protein (Suriname Z1106033) were purchased from The Native Antigen Company (Oxford, UK).

    Techniques: Binding Assay, Activity Assay, Luminex

    Reactivity of anti-ZIKV MAbs. (A) Reactivity of anti-ZIKV MAbs with ZIKV and DENV virus-like particles (VLP) using Luminex assay. ZIKV- and DENV-VLP were conjugated to MagPlex beads (Luminex) and 10,000 beads/mL of these beads mixed with 10 μg/mL to 0.0002 ng/mL anti-ZIKV MAb 102-1, 242-3, 270-12, 289-3, 306-2, 11-3, 278-11, 78-2, and 4G2 for 90 min at room temperature. (B) Western blot analysis of anti-ZIKV MAbs. ZIKV-VLP were heat denatured under nonreduced conditions at 70°C for 5 min. Samples (left, 27 ng; right, 240 ng) were electrophoresed by Wes capillary and detected by 10 μg/mL anti-ZIKV MAb clones. Left, MAb 102-1, 242-3, 270-12, 289-3, 306-2, 78-2 and 11-3. Right, 278-11. M, molecular weight marker. The estimated molecular mass of ZIKV E protein, 55 kDa; prM protein, 23 kDa.

    Journal: Journal of Virology

    Article Title: Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function

    doi: 10.1128/jvi.00071-22

    Figure Lengend Snippet: Reactivity of anti-ZIKV MAbs. (A) Reactivity of anti-ZIKV MAbs with ZIKV and DENV virus-like particles (VLP) using Luminex assay. ZIKV- and DENV-VLP were conjugated to MagPlex beads (Luminex) and 10,000 beads/mL of these beads mixed with 10 μg/mL to 0.0002 ng/mL anti-ZIKV MAb 102-1, 242-3, 270-12, 289-3, 306-2, 11-3, 278-11, 78-2, and 4G2 for 90 min at room temperature. (B) Western blot analysis of anti-ZIKV MAbs. ZIKV-VLP were heat denatured under nonreduced conditions at 70°C for 5 min. Samples (left, 27 ng; right, 240 ng) were electrophoresed by Wes capillary and detected by 10 μg/mL anti-ZIKV MAb clones. Left, MAb 102-1, 242-3, 270-12, 289-3, 306-2, 78-2 and 11-3. Right, 278-11. M, molecular weight marker. The estimated molecular mass of ZIKV E protein, 55 kDa; prM protein, 23 kDa.

    Article Snippet: A volume of 0.1 to 1.0 μg/mL ZIKV-VLP or 0.2 to 2 μg/mL ZIKV E protein in 1× kinetic buffer (Sartorius, Fremont, CA, USA) was associated with anti-ZIKV MAb for 900 s and dissociated for 1,200 s. Kinetic parameters, association constant ( k a ), and dissociation constant ( k dis ) were analyzed by Octet Data Analysis Software HT (ver.

    Techniques: Virus, Luminex, Western Blot, Clone Assay, Molecular Weight, Marker

    Summary of characterization of  anti-ZIKV  MAbs

    Journal: Journal of Virology

    Article Title: Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function

    doi: 10.1128/jvi.00071-22

    Figure Lengend Snippet: Summary of characterization of anti-ZIKV MAbs

    Article Snippet: A volume of 0.1 to 1.0 μg/mL ZIKV-VLP or 0.2 to 2 μg/mL ZIKV E protein in 1× kinetic buffer (Sartorius, Fremont, CA, USA) was associated with anti-ZIKV MAb for 900 s and dissociated for 1,200 s. Kinetic parameters, association constant ( k a ), and dissociation constant ( k dis ) were analyzed by Octet Data Analysis Software HT (ver.

    Techniques: Luminex, Western Blot

    Kinetic analysis of anti-ZIKV MAbs. Kinetic analysis was conducted by Octet HTX (Sartorius). Anti-ZIKV MAbs were conjugated to an amine-reactive 2nd generation (AR2G) biosensor at 0.1 to 0.3 μg/mL, and the association constant ( k a ) was measured over 0 to 900 s and dissociation constant ( k dis ) for 1,200 s for ZIKV-VLP or E proteins at various concentrations. (A) MAb 289-3 and 102-1 to ZIKV-VLP, 3.3 to 16.7 nM. (B) MAb 289-3 and 102-1 to ZIKV E proteins, 6.67 to 33.3 nM, red line, fitting pattern. (C) k a / k dis plot for anti-ZIKV MAbs to ZIKV-VLP and ZIKV E proteins. Blue, MAb 78-2, 289-3, 306-2 and 278-11; red, MAb 102-1, 242-3. 270-12, and 11-3. k a and k dis values were calculated by two runs, and the average values are shown. Values (nM) for equilibrium dissociation constants ( K D ) are shown for each dotted line. K D = K dis / K a .

    Journal: Journal of Virology

    Article Title: Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function

    doi: 10.1128/jvi.00071-22

    Figure Lengend Snippet: Kinetic analysis of anti-ZIKV MAbs. Kinetic analysis was conducted by Octet HTX (Sartorius). Anti-ZIKV MAbs were conjugated to an amine-reactive 2nd generation (AR2G) biosensor at 0.1 to 0.3 μg/mL, and the association constant ( k a ) was measured over 0 to 900 s and dissociation constant ( k dis ) for 1,200 s for ZIKV-VLP or E proteins at various concentrations. (A) MAb 289-3 and 102-1 to ZIKV-VLP, 3.3 to 16.7 nM. (B) MAb 289-3 and 102-1 to ZIKV E proteins, 6.67 to 33.3 nM, red line, fitting pattern. (C) k a / k dis plot for anti-ZIKV MAbs to ZIKV-VLP and ZIKV E proteins. Blue, MAb 78-2, 289-3, 306-2 and 278-11; red, MAb 102-1, 242-3. 270-12, and 11-3. k a and k dis values were calculated by two runs, and the average values are shown. Values (nM) for equilibrium dissociation constants ( K D ) are shown for each dotted line. K D = K dis / K a .

    Article Snippet: A volume of 0.1 to 1.0 μg/mL ZIKV-VLP or 0.2 to 2 μg/mL ZIKV E protein in 1× kinetic buffer (Sartorius, Fremont, CA, USA) was associated with anti-ZIKV MAb for 900 s and dissociated for 1,200 s. Kinetic parameters, association constant ( k a ), and dissociation constant ( k dis ) were analyzed by Octet Data Analysis Software HT (ver.

    Techniques:

    Binding activity of framework region (FWR) amino acid reverted anti-ZIKV MAb. (A to D) Association and dissociation analysis of FWR amino acid reverted anti-ZIKV MAbs by Octet HTX (Sartorius); 2 μg/mL MAbs were captured to protein G biosensor (Sartorius), and 3 μg/mL ZIKV E protein was associated for 600 s and dissociated for 900 s. (E to H) Reactivity of anti-ZIKV MAbs of ZIKV-VLP using Luminex assay. Blue, anti-ZIKV MAbs with matured amino acid; red, anti-ZIKV MAbs with amino acid reverted to allele. (A and E) MAb 102-1. (B and F) MAb 270-12. (C and G) MAb 289-3. (D and H) MAb 306-2.

    Journal: Journal of Virology

    Article Title: Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function

    doi: 10.1128/jvi.00071-22

    Figure Lengend Snippet: Binding activity of framework region (FWR) amino acid reverted anti-ZIKV MAb. (A to D) Association and dissociation analysis of FWR amino acid reverted anti-ZIKV MAbs by Octet HTX (Sartorius); 2 μg/mL MAbs were captured to protein G biosensor (Sartorius), and 3 μg/mL ZIKV E protein was associated for 600 s and dissociated for 900 s. (E to H) Reactivity of anti-ZIKV MAbs of ZIKV-VLP using Luminex assay. Blue, anti-ZIKV MAbs with matured amino acid; red, anti-ZIKV MAbs with amino acid reverted to allele. (A and E) MAb 102-1. (B and F) MAb 270-12. (C and G) MAb 289-3. (D and H) MAb 306-2.

    Article Snippet: A volume of 0.1 to 1.0 μg/mL ZIKV-VLP or 0.2 to 2 μg/mL ZIKV E protein in 1× kinetic buffer (Sartorius, Fremont, CA, USA) was associated with anti-ZIKV MAb for 900 s and dissociated for 1,200 s. Kinetic parameters, association constant ( k a ), and dissociation constant ( k dis ) were analyzed by Octet Data Analysis Software HT (ver.

    Techniques: Binding Assay, Activity Assay, Luminex

    FIGURE 1 Isotype specificity of ZIKV-immune sera. ELISA plates were coated with ZIKV NS1 (a, c) or ZIKV VLP (b, d), and a 1:100 dilution (n = 28) (a, b) or serial dilutions (n = 11) (c, d) of ZIKV-immune sera were added to plates. Following incubation and washes, optimized concentrations of polyclonal secondary IgG, and monoclonal Abs against the hinge or Fc portion of IgG1, IgG2, IgG3 and IgG4 Abs were added to wells (a) and (b) and IgG1 hinge Abs to (c) and (d). OD values shown at 450 nm. OD values to ZIKV VLP and ZIKV NS1 using a 1:100 dilution of ZIKV-naïve sera (n = 4), <0·2 with polyclonal secondary IgG and <0·1 with IgG1 hinge, IgG1 Fc, IgG2, IgG3 and IgG4 secondary Abs. Bars represent mean with standard error of the mean of the OD values. *P < 0·05, ***P < 0·001 and ****P < 0·0001 were obtained using the non- parametric Friedman test (three or more matched groups) with Dunn's multiple comparisons test

    Journal: Immunology

    Article Title: Non-structural protein 1-specific antibodies directed against Zika virus in humans mediate antibody-dependent cellular cytotoxicity.

    doi: 10.1111/imm.13380

    Figure Lengend Snippet: FIGURE 1 Isotype specificity of ZIKV-immune sera. ELISA plates were coated with ZIKV NS1 (a, c) or ZIKV VLP (b, d), and a 1:100 dilution (n = 28) (a, b) or serial dilutions (n = 11) (c, d) of ZIKV-immune sera were added to plates. Following incubation and washes, optimized concentrations of polyclonal secondary IgG, and monoclonal Abs against the hinge or Fc portion of IgG1, IgG2, IgG3 and IgG4 Abs were added to wells (a) and (b) and IgG1 hinge Abs to (c) and (d). OD values shown at 450 nm. OD values to ZIKV VLP and ZIKV NS1 using a 1:100 dilution of ZIKV-naïve sera (n = 4), <0·2 with polyclonal secondary IgG and <0·1 with IgG1 hinge, IgG1 Fc, IgG2, IgG3 and IgG4 secondary Abs. Bars represent mean with standard error of the mean of the OD values. *P < 0·05, ***P < 0·001 and ****P < 0·0001 were obtained using the non- parametric Friedman test (three or more matched groups) with Dunn's multiple comparisons test

    Article Snippet: Briefly, 96- well plates were coated overnight with 20 ng/well of ZIKV virus- like particles (Suriname Z1106033) or 50 ng/ml ZIKV NS1 (Uganda MR766) (Native Antigen Company, Oxfordshire, UK).

    Techniques: Enzyme-linked Immunosorbent Assay, Incubation

    FIGURE 2 Frequencies of ZIKV-specific IgG and IgG1 B-cell responses using fluorescently labelled ZIKV or ZIKV NS1. PBMCs from ZIKV-immune and ZIKV-naïve donors were stimulated in vitro for seven days with r848 + rIL-2. FluoroSpot plates were coated with IgG and IgG1 capture Abs. (a) Images of wells containing media, total IgG, ZIKV and ZIKV NS1 IgG- or IgG1-specific MBCs from one representative donor. (b) Frequencies of ZIKV (green) and NS1-specific (red) ASCs per 106 input cells in MBC cultures from 12 ZIKV-immune and three ZIKV- naïve donors. Values are the mean of duplicate wells for each condition. The supernatants were evaluated for isotype-specific Abs to (c) ZIKV VLPs and (D) ZIKV NS1. *P < 0·05, **P < 0·01 and ****P < 0·0001 were obtained using the non-parametric Mann-Whitney or Friedman test (three or more matched groups) with Dunn's multiple comparisons test

    Journal: Immunology

    Article Title: Non-structural protein 1-specific antibodies directed against Zika virus in humans mediate antibody-dependent cellular cytotoxicity.

    doi: 10.1111/imm.13380

    Figure Lengend Snippet: FIGURE 2 Frequencies of ZIKV-specific IgG and IgG1 B-cell responses using fluorescently labelled ZIKV or ZIKV NS1. PBMCs from ZIKV-immune and ZIKV-naïve donors were stimulated in vitro for seven days with r848 + rIL-2. FluoroSpot plates were coated with IgG and IgG1 capture Abs. (a) Images of wells containing media, total IgG, ZIKV and ZIKV NS1 IgG- or IgG1-specific MBCs from one representative donor. (b) Frequencies of ZIKV (green) and NS1-specific (red) ASCs per 106 input cells in MBC cultures from 12 ZIKV-immune and three ZIKV- naïve donors. Values are the mean of duplicate wells for each condition. The supernatants were evaluated for isotype-specific Abs to (c) ZIKV VLPs and (D) ZIKV NS1. *P < 0·05, **P < 0·01 and ****P < 0·0001 were obtained using the non-parametric Mann-Whitney or Friedman test (three or more matched groups) with Dunn's multiple comparisons test

    Article Snippet: Briefly, 96- well plates were coated overnight with 20 ng/well of ZIKV virus- like particles (Suriname Z1106033) or 50 ng/ml ZIKV NS1 (Uganda MR766) (Native Antigen Company, Oxfordshire, UK).

    Techniques: In Vitro, MANN-WHITNEY

    FIGURE 3 Opsonization and ADCC activity of a ZIKV NS1 monoclonal Ab. (a) K562 cells transfected with DC-SIGN were infected with ZIKV (moi = 0·1 and 1), and 24 h later, the expression of E and NS1 was measured with monoclonal Abs 4G2 and B4 respectively. (b) Opsonization of ZIKV NS1-transfected CEM-NKR cells with a mAb to ZIKV NS1 from Native Antigen Company. CEM-NKR cells transfected with ZIKV NS1 (c and d) or control CEM-NKR cells (e and f) were opsonized with a ZIKV NS1 mAb (d and f), added to PBMC. A standard lymphocyte gate based upon light scatter properties followed by selection of singlet viable cells and dump channel exclusion (CD3− T cells) defined the non-T-cell lymphocyte population, and Abs to CD16 and CD56 identified NK cells

    Journal: Immunology

    Article Title: Non-structural protein 1-specific antibodies directed against Zika virus in humans mediate antibody-dependent cellular cytotoxicity.

    doi: 10.1111/imm.13380

    Figure Lengend Snippet: FIGURE 3 Opsonization and ADCC activity of a ZIKV NS1 monoclonal Ab. (a) K562 cells transfected with DC-SIGN were infected with ZIKV (moi = 0·1 and 1), and 24 h later, the expression of E and NS1 was measured with monoclonal Abs 4G2 and B4 respectively. (b) Opsonization of ZIKV NS1-transfected CEM-NKR cells with a mAb to ZIKV NS1 from Native Antigen Company. CEM-NKR cells transfected with ZIKV NS1 (c and d) or control CEM-NKR cells (e and f) were opsonized with a ZIKV NS1 mAb (d and f), added to PBMC. A standard lymphocyte gate based upon light scatter properties followed by selection of singlet viable cells and dump channel exclusion (CD3− T cells) defined the non-T-cell lymphocyte population, and Abs to CD16 and CD56 identified NK cells

    Article Snippet: Briefly, 96- well plates were coated overnight with 20 ng/well of ZIKV virus- like particles (Suriname Z1106033) or 50 ng/ml ZIKV NS1 (Uganda MR766) (Native Antigen Company, Oxfordshire, UK).

    Techniques: Activity Assay, Transfection, Infection, Expressing, Control, Selection

    FIGURE 4 NK cell activation and degranulation in the presence of ZIKV- immune sera. 1:100 dilution and 1:1600 dilution of polyclonal sera from ZIKV- immune individuals were evaluated for their ability to mediate ADCC of ZIKV NS1 CEM-NKR cells using intracellular cytokine assays. Shown are the frequencies of NK cells that (a) secrete IFN-γ, (B) express CD107 or (C) express both CD107 and IFN-γ in the presence of ZIKV-immune sera. Background levels were subtracted

    Journal: Immunology

    Article Title: Non-structural protein 1-specific antibodies directed against Zika virus in humans mediate antibody-dependent cellular cytotoxicity.

    doi: 10.1111/imm.13380

    Figure Lengend Snippet: FIGURE 4 NK cell activation and degranulation in the presence of ZIKV- immune sera. 1:100 dilution and 1:1600 dilution of polyclonal sera from ZIKV- immune individuals were evaluated for their ability to mediate ADCC of ZIKV NS1 CEM-NKR cells using intracellular cytokine assays. Shown are the frequencies of NK cells that (a) secrete IFN-γ, (B) express CD107 or (C) express both CD107 and IFN-γ in the presence of ZIKV-immune sera. Background levels were subtracted

    Article Snippet: Briefly, 96- well plates were coated overnight with 20 ng/well of ZIKV virus- like particles (Suriname Z1106033) or 50 ng/ml ZIKV NS1 (Uganda MR766) (Native Antigen Company, Oxfordshire, UK).

    Techniques: Activation Assay

    FIGURE 5 Opsonization and target cell lysis using an NK-TVA image cytometry assay. (a) Opsonization of ZIKV NS1 CEM-NKR cells by ZIKV convalescent sera. (b) Representative images of wells acquired by an ImmunoSpot S5 Analyser of an NK-TVA assay where ethanol, ZIKV NS1 or IgG Ab was added to the wells containing effector and target cells. (c) Using an optimized number of target cells, effector PBMC as a source of NK cells and different dilutions of naïve sera (n = 5), positive control sera that opsonized ZIKV NS1 CEM-NKR targets (n = 5) and experimental sera (n = 12), the loss of target cells at the single-cell level was measured by the NK-TVA image cytometry assay and calculated as a percentage of lysed target cells. *P < 0·05 and **P < 0·01 were obtained using a Kruskal–Wallis test with Dunn's multiple comparisons test

    Journal: Immunology

    Article Title: Non-structural protein 1-specific antibodies directed against Zika virus in humans mediate antibody-dependent cellular cytotoxicity.

    doi: 10.1111/imm.13380

    Figure Lengend Snippet: FIGURE 5 Opsonization and target cell lysis using an NK-TVA image cytometry assay. (a) Opsonization of ZIKV NS1 CEM-NKR cells by ZIKV convalescent sera. (b) Representative images of wells acquired by an ImmunoSpot S5 Analyser of an NK-TVA assay where ethanol, ZIKV NS1 or IgG Ab was added to the wells containing effector and target cells. (c) Using an optimized number of target cells, effector PBMC as a source of NK cells and different dilutions of naïve sera (n = 5), positive control sera that opsonized ZIKV NS1 CEM-NKR targets (n = 5) and experimental sera (n = 12), the loss of target cells at the single-cell level was measured by the NK-TVA image cytometry assay and calculated as a percentage of lysed target cells. *P < 0·05 and **P < 0·01 were obtained using a Kruskal–Wallis test with Dunn's multiple comparisons test

    Article Snippet: Briefly, 96- well plates were coated overnight with 20 ng/well of ZIKV virus- like particles (Suriname Z1106033) or 50 ng/ml ZIKV NS1 (Uganda MR766) (Native Antigen Company, Oxfordshire, UK).

    Techniques: Lysis, Cytometry, Positive Control